Skip to main navigation Skip to search Skip to main content

Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5

  • Aren Bezdjian
  • , Hanneke Bruijnzeel*
  • , Julia Pagel
  • , Sam J. Daniel
  • , Hans G.X.M. Thomeer
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
1 Downloads (Pure)

Abstract

Introduction: Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disease affecting the cytotoxic pathway. Due to the recent advances in molecular diagnosis, immuno-chemo therapy, and hematopoietic stem cell transplantation treatment, FHL survival rates have drastically increased. Case Presentation: Herein, we describe a case of FHL type 5 presenting with low-frequency sensorineural hearing loss. Alongside our reported case, 6 additional patients were identified in the literature. Management and Outcome: The progressive nature of FHL disorder may cause bilateral, low-frequency, irreversible sensorineural hearing loss. This type of hearing loss should be considered among the long-term sequelea presenting with FHL5. Discussion: We recommend audiological evaluation at initial FHL5 diagnosis to assess for hearing functions. Follow-up in audiology should be part of the long-term monitoring of patients with FHL5 as hearing loss could develop long after diagnosis.

Original languageEnglish
Pages (from-to)409-413
Number of pages5
JournalAnnals of Otology, Rhinology and Laryngology
Volume127
Issue number6
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • hemophagocytic lymphohistiocytosis
  • sensorineural hearing loss
  • STXBP2 protein

Fingerprint

Dive into the research topics of 'Low-Frequency Sensorineural Hearing Loss in Familial Hemophagocytic Lymphohistiocytosis Type 5'. Together they form a unique fingerprint.

Cite this